A randomized open-label controlled clinical study to evaluate the efficacy of Chandana Anjana and Tila Taila Padabhyanga in the management of Asthenopia. - NI

Dr Akshat Vashisth0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•1. Subjects within the age group between 21 to 40 years irrespective of gender, caste, religion, and socio-economic status.
•2. Subjects having at least two symptoms under diagnostic criteria.
•3. Subjects having vision as 6/6 or 6/6 blur or N6 or N6 blur up to ± 1D.
•4. Subjects willing to participate in the study with informed consent.

•1. History of any intraocular surgery.
•2. Subjects having any ocular trauma.
•3. Subjects having any uncontrolled systemic illness that can interfere with the course of disease and treatment.
•4. Subjects diagnosed with infective diseases of the eye like Conjunctivitis, Uveitis, Scleritis, Keratitis, Stye, Trachoma, Endophthalmitis, Blepharitis, Retinitis and Dacryocystitis.
•5. Subjects having refractive errors due to pathological conditions like Cataracts, Corneal opacity, Keratoconus, and Glaucoma.
•6. Pregnant and lactating women.

发起方

Dr Akshat Vashisth